[Progestins and hemostasis].
Progesterone and the progestins do not lead to significant changes of the hemostatic system, which could have a decisive action on hemostasis disturbances. This is true for oral and parenteral application as well. In the oncological high dose therapy with progestins remarkable negative effects on the parameters of the hemostatic system, which is already activated in cancer patients, could not be demonstrated.
Schindler
A E
AE
Zentrum für Frauenheilkunde, Universitätsklinikum Essen.
D004305:Dose-Response Relationship, Drug; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood / Q000188:drug therapy; D006487:Hemostasis / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood / Q000139:chemically induced
D011372:Progestins